Carol Giltner Gallagher, Director at Atara Biotherapeutics, Inc. (ATRA), sold 2,366 shares at $46.50 ($110K) on 2018-02-16, disclosed to the SEC on 2018-02-20.
Seasonal sale ($110k) by Director — this insider has traded ATRA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.50 | 1,183 | $55K | 50.0% |
| 2 | $46.50 | 1,183 | $55K | 50.0% |
| Total | $46.50 avg | 2,366 | $110K | 100% |
| Filing → |
| ATRA | SELL | 2018-06-19 | $112K | — | Filing → |
| ATRA | SELL | 2018-05-16 | $13K | — | Filing → |
| ATRA | SELL | 2017-11-17 | $17K | — | Filing → |